483
Pillar Biosciences Inc.FDA 483 - Pillar Biosciences Inc. - September 16, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Pillar Biosciences Inc. in Natick, MA, revealed significant deficiencies in their corrective and preventive action (CAPA) procedures. The firm failed to consistently meet CAPA timeline requirements, adequately document extensions, and ensure consistency between its CAPA-related standard operating procedures. These issues indicate a breakdown in the firm's quality system regarding corrective and preventive actions.
Open in Dashboard
ID · f5236b8a-243d-4904-8646-ff97513a53eb